All News

Drinks for Everyone: Inside the Mind of a Serial Plaintiff

Tort reformers have targeted the role of serial plaintiffs, with some calling it a factor in frivolous litigation. With the role of serial litigants a hot topic in the law, litigators would be well-served to understand just what goes on in the mind of a frequent filer. Plaintiffs who file…

Greenberg Traurig, Goodwin Act on Japanese Pharma’s .4B American Acquisition

Greenberg Traurig and Goodwin Procter are advising on the $2.4 billion sale of American cancer drugmaker Deciphera to Japanese company ONO Pharmaceutical. Under the terms of the agreement, ONO will acquire all outstanding shares of Deciphera, a 2003-founded biopharmaceutical company focused on developing cancer drugs, for $25.60 per share in…

Fraudulent Claims in Class Actions and Mass Torts Are Skyrocketing

Fraudulent class actions and mass tort claims are rampant, while digital payments are fast becoming more common for claim disbursement, according to the “2024 Digital Payments in Class Actions and Mass Torts” report by Western Alliance Bank and its wholly owned subsidiary digital payments platform Digital Disbursements. The report, which…

Nuclear Verdicts Poised to Rise But Some Governors Fight Back

An independent communications and research firm released a report that shows nuclear verdicts—judgments over $10 million—against corporate defendants have increased by nearly 30% in the last year, and that state governors have had an outsized role in the results. Phil Singer, CEO of  Marathon Strategies, noted Florida had historically been…